Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey.
Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin Z, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B.
Salihoglu A, et al. Among authors: topcuoglu p.
Ann Hematol. 2015 Mar;94(3):415-20. doi: 10.1007/s00277-014-2215-9. Epub 2014 Sep 18.
Ann Hematol. 2015.
PMID: 25231929
Free PMC article.